Bioactive compounds in wine: Resveratrol, hydroxytyrosol and melatonin: A review

被引:285
作者
Fernandez-Mar, M. I. [1 ]
Mateos, R. [2 ]
Garcia-Parrilla, M. C. [3 ]
Puertas, B. [1 ]
Cantos-Villar, E. [1 ]
机构
[1] Inst Invest & Formac Agr & Pesquera IFAPA, Cadiz, Spain
[2] Inst Ciencia & Tecnol Alimentos & Nutr CSIC, Dept Metab & Nutr, E-28040 Madrid, Spain
[3] Univ Seville, Area Nutr & Bromatol, Fac Farm, E-41012 Seville, Spain
关键词
Antioxidant; Bioactive; Resveratrol; Hydroxytyrosol; Melatonin; Wine; VIRGIN OLIVE OIL; PERFORMANCE LIQUID-CHROMATOGRAPHY; OXIDATIVE DNA-DAMAGE; VITRO ANTIMICROBIAL ACTIVITY; BLOOD MONONUCLEAR-CELLS; LOW-DENSITY-LIPOPROTEIN; TRANS-RESVERATROL; RED WINE; PHENOLIC-COMPOUNDS; FOOD-INTAKE;
D O I
10.1016/j.foodchem.2011.08.023
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Regular moderate wine consumption is often associated with reduced morbidity and mortality from a variety of chronic diseases in which inflammation is the root cause. This review is focused on three of the numerous bioactive compounds present in wine: resveratrol, hydroxytyrosol and melatonin. Resveratrol and hydroxytyrosol are polyphenols. Melatonin, recently described in wine, is an indoleamine. Their structures, concentrations in wine, bioavailability, pharmacokinetic and health promoting properties are reviewed. Resveratrol seems to be one of the most promising compounds due to its bioactivity, with wine being the main source of resveratrol in diet. Hydroxytyrosol, which its main source in diet is olive oil has been also found in both red and white wine in considerable amounts. Melatonin has been found in wine in low amounts. However, both high bioactivity and bioavailability have been attributed to it. They show antioxidant, cardioprotective, anticancer, antidiabetic, neuroprotective and antiaging activities. However, human studies are still in the initial stages and therefore further studies are needed. Published by Elsevier Ltd.
引用
收藏
页码:797 / 813
页数:17
相关论文
共 254 条
[91]   Inhibitory action of purified hydroxytyrosol from stored olive mill waste on intestinal disaccharidases and lipase activities and pancreatic toxicity in diabetic rats [J].
Hamden, Khaled ;
Allouche, Noureddine ;
Jouadi, Bessam ;
El-Fazaa, Saloua ;
Gharbi, Najoua ;
Carreau, Serge ;
Damak, Mohamed ;
Elfeki, Abdelfattah .
FOOD SCIENCE AND BIOTECHNOLOGY, 2010, 19 (02) :439-447
[92]   Hypoglycemic and antioxidant effects of phenolic extracts and purified hydroxytyrosol from olive mill waste in vitro and in rats [J].
Hamden, Khaled ;
Allouche, Noureddine ;
Damak, Mohamed ;
Elfeki, Abdelfattah .
CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 180 (03) :421-432
[93]   Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells [J].
Han, Junkyu ;
Talorete, Terence P. N. ;
Yamada, Parida ;
Isoda, Hiroko .
CYTOTECHNOLOGY, 2009, 59 (01) :45-53
[94]  
Hao HD, 2004, J MED FOOD, V7, P290, DOI 10.1089/jmf.2004.7.290
[95]   Melatonin [J].
Hardeland, R ;
Pandi-Perumal, SR ;
Cardinali, DP .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (03) :313-316
[96]   THE SIGNIFICANCE OF THE METABOLISM OF THE NEUROHORMONE MELATONIN - ANTIOXIDATIVE PROTECTION AND FORMATION OF BIOACTIVE SUBSTANCES [J].
HARDELAND, R ;
REITER, RJ ;
POEGGELER, B ;
TAN, DX .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1993, 17 (03) :347-357
[97]   Melatonin, a potent agent in antioxidative defense: Actions as a natural food constituent, gastrointestinal factor, drug and prodrug [J].
Hardeland R. ;
Pandi-Perumal S.R. .
Nutrition & Metabolism, 2 (1)
[98]   Resveratrol - A multitargeted agent for age-associated chronic diseases [J].
Harikumar, Kuzhuvelil B. ;
Aggarwal, Bharat B. .
CELL CYCLE, 2008, 7 (08) :1020-1035
[99]  
HATTORI A, 1995, BIOCHEM MOL BIOL INT, V35, P627
[100]   Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol [J].
Heredia, A ;
Davis, C ;
Redfield, R .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (03) :246-255